Drug Profile
Research programme: enterovirus vaccine - GenVec
Alternative Names: EV-D68 vaccine - GenVecLatest Information Update: 28 Mar 2019
Price :
$50
*
At a glance
- Originator GenVec
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Enterovirus infections
Most Recent Events
- 28 Mar 2019 No recent reports of development identified for research development in Enterovirus infections(Prevention) in USA (Parenteral)
- 16 Jun 2017 GenVec has been acquired by Intrexon Corporation
- 01 Feb 2015 Early research in Enterovirus infections (Prevention) in USA (Parenteral)